Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mTORC1-mediated cholesterol biosynthesis pathway describes the regulatory role of mTORC1 in controlling cellular cholesterol synthesis. mTORC1 activates SREBP-2, a master transcription factor for cholesterol synthesis genes, and regulates cholesterol trafficking to maintain low ER cholesterol levels, further sustaining SREBP-2 activity. This pathway is crucial for cell growth and function and dysregulation can contribute to various diseases.
Regulation of SREBP-2 activation and downstream cholesterol synthesis gene expression via mTORC1 signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mTORC1-Mediated Cholesterol Biosynthesis Pathway (N/A).